Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Natarajan Sethuraman currently holds 242,224 shares of Entrada Therapeutics, Inc. (TRDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Natarajan Sethuraman has been a net seller of TRDA stock. They have purchased $0 and sold $752.7K worth of shares.
Natarajan Sethuraman's most recent insider trade was on Mar 3, 2026, when they sold 7,577 shares at $11.76 per share.
Natarajan Sethuraman serves as Executive at Entrada Therapeutics, Inc. (TRDA). They have executed 32 insider transactions totaling $752.7K over their tenure at the company.
Natarajan Sethuraman holds the position of Executive at Entrada Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Natarajan Sethuraman has shown a selling trading pattern, with $0 in total purchases and $752.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Natarajan Sethuraman was on Jul 11, 2023, when they sold $267.9K worth of TRDA shares. This transaction involved 14,852 shares at $18.04 per share.
Natarajan Sethuraman currently owns 242,224 shares of Entrada Therapeutics, Inc. (TRDA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Natarajan Sethuraman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Natarajan Sethuraman has 32 Form 4 filings on record as an insider at Entrada Therapeutics, Inc..
Set alerts for Natarajan Sethuraman and 40,000+ other insiders.